Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.
포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.
터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
cals PLC - London-based pharmaceutical company - Reports that Bassam Kanaan, executive vice president of corporate dev ...
Hikma Pharmaceuticals Plc 13 August 2024 Hikma Pharmaceuticals PLC (the "Company") LONDON, 13 August 2024: Hikma Pharmaceuticals PLC (LSE:...
Hikma Pharmaceuticals PLC on Thursday increased its interim dividend following double-digit growth across the busines ...
Hikma Pharmaceuticals Plc 08 August 2024 Hikma delivers strong H1 performance and upgrades Group guidance London, 8 August 2024 - Hikma...
Hikma Pharmaceuticals Plc 29 July 2024 Hikma Pharmaceuticals PLC Director Declaration LONDON, 29 July 2024: Pursuant to Listing Rule 9.6.14...
Hikma Pharmaceuticals Plc 15 July 2024 London, 15 July 2024 - Hikma Pharmaceuticals PLC (Hikma, Group), will announce its interim financial...
Hikma Pharmaceuticals Plc 01 July 2024 Hikma Pharmaceuticals PLC (the Company) Total Voting Rights and Capital LONDON, 1 July 2024 - In...
Hikma Pharmaceuticals Plc 27 June 2024 Hikma Pharmaceuticals PLC Director Declaration In accordance with Listing Rule 9.6.14, Hikma...
Hikma Pharmaceuticals PLC on Monday bolstered its US and injectables business with the purchase of assets from Denmar ...
Hikma Pharmaceuticals Plc 17 June 2024 Hikma acquires Xellia's differentiated portfolio and enhances Injectables pipeline, manufacturing...
Shares in Hikma Pharmaceuticals PLC rose on Tuesday as analysts at Citi increased the bank's net present value price ...
Hikma Pharmaceuticals Plc 05 June 2024 Hikma Pharmaceuticals PLC Notification and public disclosure of transactions by persons discharging...
귀하가 조회한 주식이 이 박스에 나타나며 쉽게 최근 시세로 돌아갈 수 있습니다.
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관